Ezetimibe/rosuvastatin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ezetimibe/rosuvastatin
I
- Icar Prenatal Chewable Calcium (calcium carbonate)
- Iclevia (ethinyl estradiol / levonorgestrel)
- Iclusig (ponatinib)
- Idacio (adalimumab)
- idelalisib
- Idhifa (enasidenib)
- Ilosone (erythromycin)
- Imdelltra (tarlatamab)
- Implanon (etonogestrel)
- Inbrija (levodopa)
- Incassia (norethindrone)
- indinavir
- Infergen (interferon alfacon-1)
- Inflectra (infliximab)
- infliximab
- Intelence (etravirine)
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-2b / ribavirin
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- Intron A (interferon alfa-2b)
- Introvale (ethinyl estradiol / levonorgestrel)
- Invirase (saquinavir)
- iodoquinol
- Iosopan (magaldrate)
- ipilimumab
- Isibloom (desogestrel / ethinyl estradiol)
- IsonaRif (isoniazid / rifampin)
- isoniazid
- isoniazid / pyrazinamide / rifampin
- isoniazid / rifampin
- itraconazole
- ivosidenib
- ixabepilone
- ixazomib
- Ixempra (ixabepilone)
- Ixifi (infliximab)
More about ezetimibe / rosuvastatin
- ezetimibe/rosuvastatin consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.